Pulmonary Fibrosis Latest Advances

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

Journal: Theranostics

Published: September 08, 2026

The regulatory effect of PI3K/Akt/HIF-1α glycolytic signaling pathway on the metabolites in urine of mice with bleomycin-induced pulmonary fibrosis model

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: September 07, 2026

Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study.

Journal: Thoracic research and practice

Published: September 04, 2026

Critical role for the TGF-β1/mTORC1 signaling axis in defining the transcriptional identity of CTHRC1+ pathologic fibroblasts.

Journal: Science advances

Published: September 02, 2026

Clinical impact of hospitalization in patients with idiopathic pulmonary fibrosis: A retrospective cohort study.

Journal: Therapeutic advances in respiratory disease

Published: September 02, 2026

Analysis of Prescription Medication Rules of Chinese Herbal Medicine for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Based on Data Mining.

Journal: Journal of visualized experiments : JoVE

Published: September 02, 2026

An Evidence-Based Exposure Questionnaire for Interstitial Lung Disease: EXPO-ILD.

Journal: CHEST pulmonary

Published: September 01, 2026

Extra-articular rheumatoid arthritis: example of RA-associated interstitial lung disease.

Journal: EULAR rheumatology open

Published: September 01, 2026

An NFATC4 phospho-switch links matrix stiffness to fibroblast fate.

Journal: The Journal of clinical investigation

Published: September 01, 2026

Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study.

Journal: Therapeutic advances in respiratory disease

Published: August 31, 2026

A rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred - A case series.

Journal: Therapeutic advances in respiratory disease

Published: August 31, 2026

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Journal: European journal of pharmacology

Published: August 31, 2026

Pulmonary Fibrosis Latest Advances

Find the Latest Research About Pulmonary Fibrosis

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

The regulatory effect of PI3K/Akt/HIF-1α glycolytic signaling pathway on the metabolites in urine of mice with bleomycin-induced pulmonary fibrosis model

The regulatory effect of PI3K/Akt/HIF-1α glycolytic signaling pathway on the metabolites in urine of mice with bleomycin-induced pulmonary fibrosis model

Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study.

Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study.

Critical role for the TGF-β1/mTORC1 signaling axis in defining the transcriptional identity of CTHRC1+ pathologic fibroblasts.

Critical role for the TGF-β1/mTORC1 signaling axis in defining the transcriptional identity of CTHRC1+ pathologic fibroblasts.

Clinical impact of hospitalization in patients with idiopathic pulmonary fibrosis: A retrospective cohort study.

Clinical impact of hospitalization in patients with idiopathic pulmonary fibrosis: A retrospective cohort study.

Analysis of Prescription Medication Rules of Chinese Herbal Medicine for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Based on Data Mining.

Analysis of Prescription Medication Rules of Chinese Herbal Medicine for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Based on Data Mining.

An Evidence-Based Exposure Questionnaire for Interstitial Lung Disease: EXPO-ILD.

An Evidence-Based Exposure Questionnaire for Interstitial Lung Disease: EXPO-ILD.

Extra-articular rheumatoid arthritis: example of RA-associated interstitial lung disease.

Extra-articular rheumatoid arthritis: example of RA-associated interstitial lung disease.

An NFATC4 phospho-switch links matrix stiffness to fibroblast fate.

An NFATC4 phospho-switch links matrix stiffness to fibroblast fate.

Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study.

Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study.

A rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred - A case series.

A rare TERT p.Ala880Thr variant associated with familial pulmonary fibrosis and multisystem involvement: Intrafamilial heterogeneity in a Vietnamese kindred - A case series.

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].